Telix Pharmaceuticals Ltd News

Telix Pharmaceuticals Ltd: Telix to Acquire RLS for US Manufacturing and Distribution

Sep 23 06:25

Telix Pharmaceuticals Ltd: Telix Submits NDA for TLX101-CDx Brain Cancer Imaging Agent

Aug 28 06:17

Telix Pharmaceuticals Ltd: Telix Reorganisation to Deliver on Strategic Priorities

Aug 27 06:08

Telix Pharmaceuticals Ltd: Telix 2024 Half-Year Results Investor Webcast Notification

Aug 13 06:15

Telix Pharmaceuticals Ltd: Investor Conference Call - TLX250-CDx BLA Filing Update

Jul 31 07:57

Telix Pharmaceuticals Ltd: BLA Filing Update for Renal Cancer Imaging Agent TLX250-CDx

Jul 31 07:56

Telix Pharmaceuticals Ltd: Telix Completes A$650 Million of Convertible Bonds

Jul 30 11:02

Telix Pharmaceuticals Ltd: FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent

Jul 24 07:28

Telix Pharmaceuticals Ltd: Telix Successfully Prices A$650M Convertible Bonds

Jul 24 06:57

Telix Pharmaceuticals Ltd: Telix Q2 2024 Revenue/Business Highlights, Guidance Upgrade

Jul 18 06:32

Telix Pharmaceuticals Ltd: CMS proposes payment improvement for radiopharma diagnostics

Jul 11 07:49

Telix Pharmaceuticals Ltd: Pending Release of Shares from Voluntary Escrow

Jul 3 06:24

Telix Pharmaceuticals Ltd: Appendix 3Y Change in Director Interests - C Behrenbruch

Jun 27 06:20

Telix Pharmaceuticals Ltd: Telix Elects to Withdraw from Proposed U.S. Listing

Jun 14 06:52

Telix Pharmaceuticals Ltd: Trading Halt

Jun 13 06:31

Telix Pharmaceuticals Ltd: Telix Launches Proposed US IPO

Jun 6 06:21

Telix Pharmaceuticals Ltd: Telix Completes TLX250-CDx (Zircaix) BLA Submission

Jun 3 06:21

Telix Pharmaceuticals Ltd: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS

May 31 06:18

Telix Pharmaceuticals Ltd: Response to ASX Query

May 28 07:58

Telix Pharmaceuticals Ltd: Telix Submits NDA for New Prostate Cancer Imaging Agent

May 27 06:29